Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Comments

High-throughput genomic technology in research and clinical management of breast cancer. Molecular signatures of progression from benign epithelium to metastatic breast cancer

Karin Rennstam email and Ingrid Hedenfalk email

Breast Cancer Research 2006, 8:213doi:10.1186/bcr1528

No comments have yet been made on this article

Post a comment

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.